Oncologists, oncology nurse practitioners, and oncology physician assistants.
Dr. Hurvitz and Dr Tolaney share key data and expert perspectives on approved and emerging HER-targeted therapies for metastatic breast cancer.
Upon completion of this educational activity, learners should be better able to:
- DESCRIBE the latest clinical advances in HER-directed therapies for advanced or metastatic breast cancer
- SELECT therapy for advanced or metastatic HER2-positive breast cancer according to the latest evidence and efficacy and safety data
- DISCUSS available resources for caring for breast cancer patients during a global pandemic